Exploring Non-Liver Transplant Therapies for ATTR Amyloidosis in 2022
×

Trusted Resources: Education

Scientific literature and patient education texts

Back to Education / Patient Education

Non-Liver Transplant Therapies for ATTR Amyloidosis 2022

key information

source: Amyloidosis Support Groups

year: 2022

authors: Jeffrey Zonder

summary/abstract:

Non-Liver Transplant Therapies for ATTR Amyloidosis 2022 lists different medications and therapies for treating ATTR Amyloidosis, a genetic disorder characterized by abnormal deposits of a protein called transthyretin (TTR). The table is divided into 3 categories: Tetramer Stabilizers, RNA-directed Therapies, and Gene Editing Therapies. Some of the therapies listed, such as Patisiran, Tafamidis, Inotersen, and Vutrisiran have FDA approval, while others are still in development.

 

read more

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close